TCRX vs TGT · rev $2.0M vs P/E 17, rev $51.98B
Tscan Therapeutics Inc (TCRX) versus Target Corporation (TGT) — a side-by-side from cached financials, not a winner call.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Target Corporation (TGT) is a discount stores company listed on NYSE. It is led by Michael J. Fiddelke.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
Latest reported TGT revenue for 2026-08-01 was $51.98B. Net income was $2.66B. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
TCRX currently screens at market cap $62.1M. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
Not investment advice. Open the TCRX and TGT stock pages for the full models.
Not investment advice.